Rule 8 of Annex VIII to Regulation (EU) 2017/745 classifies long-term surgically invasive devices and implantable devices. The default class under Rule 8 is Class IIb. The rule escalates to Class III for a defined list of cases: devices placed in the heart or central circulatory system, devices in contact with the central nervous system, devices with a biological effect or intended to be wholly or mainly absorbed, devices undergoing chemical change in the body (teeth excluded), devices administering medicinal products, active implantable devices and their accessories, breast implants and surgical meshes, total or partial joint replacements (with specific component exclusions), and spinal disc replacement implants and devices in contact with the spinal column (with specific exceptions). Classification is governed by MDR Article 51, and the authoritative interpretation guide is MDCG 2021-24 (October 2021).

By Tibor Zechmeister and Felix Lenhard. Last updated 10 April 2026.

TL;DR

  • Rule 8 applies to all long-term surgically invasive devices and all implantable devices, with a Class IIb default and a long list of Class III escalations.
  • "Long-term" in Annex VIII means continuous intended use for more than 30 days. This is a duration concept, not a product lifetime concept.
  • "Implantable" is a specific defined term in Annex VIII Section 1 and captures devices intended to remain in the body after the procedure, as well as devices partially absorbed where any part is intended to remain for at least 30 days.
  • The Class III escalation list in Rule 8 is closed. If your device does not hit one of the listed escalations, it stays at Class IIb. If it hits one, it is Class III. There is no middle ground.
  • Active implantable devices (pacemakers, implantable neurostimulators, cochlear implants, implantable infusion systems) are always Class III under Rule 8, together with their accessories.
  • Classification is governed by MDR Article 51 and the manufacturer's own assessment, cross-checked with MDCG 2021-24. A Notified Body can dispute the class during conformity assessment, and late disputes are expensive.

Why Rule 8 matters more than any other invasive rule

Most of the high-stakes implant categories. Pacemakers, hip and knee replacements, stents, heart valves, spinal cages, breast implants, intraocular lenses, drug-delivery implants. Live in Rule 8. The rule is short to read and punishing to misapply. A founder who reads Rule 8 casually will usually land on "Class IIb" and stop. The escalations to Class III sit immediately below the default clause, and they catch a meaningful share of implantable startups on the first real reading.

This post walks through the rule in the order the Regulation presents it: the text itself, the duration definition that gates the rule, the implantable definition that widens it, the Class III escalation list, worked examples of where startup devices land, and the misclassifications we see most often. The source for every claim is Annex VIII of Regulation (EU) 2017/745 and MDCG 2021-24 (October 2021). Nothing here substitutes for reading the actual Regulation text.

The Rule 8 text, decoded

Rule 8 is the long-term and implantable rule inside the surgically invasive family that starts at Rule 6. In substance, the rule runs like this:

  • The default for all implantable devices and for long-term surgically invasive devices is Class IIb.
  • The rule then lists specific categories that escalate the device to Class III. These categories are the tightest part of the rule and the part that needs the most careful reading.

The categories that escalate to Class III under Rule 8 are:

  • Devices intended to be placed in the heart or the central circulatory system, or in direct contact with these parts of the body.
  • Devices intended to come into direct contact with the central nervous system.
  • Devices intended to have a biological effect or to be wholly or mainly absorbed.
  • Devices intended to undergo chemical change in the body, except if the devices are placed in the teeth.
  • Devices intended to administer medicinal products.
  • Active implantable devices and their accessories.
  • Breast implants and surgical meshes.
  • Total or partial joint replacements, with the exception of ancillary components such as screws, wedges, plates, and instruments.
  • Spinal disc replacement implants and implantable devices that come into contact with the spinal column, with the exception of components such as screws, wedges, plates, and instruments.

Reading Rule 8 properly means reading Section 1 of Annex VIII in parallel, because the rule uses defined terms. "long-term," "implantable device," "central circulatory system," "central nervous system," and "active implantable device". And the definitions change the scope in ways the plain English does not suggest. The rest of this post walks through those definitions before looking at the examples.

What "long-term" means in Annex VIII

Annex VIII Section 1 defines three durations for continuous use:

  • Transient: normally intended for continuous use for less than 60 minutes.
  • Short-term: normally intended for continuous use for between 60 minutes and 30 days.
  • Long-term: normally intended for continuous use for more than 30 days.

Two things matter about this definition in practice. First, duration is continuous use, not calendar time. A device used intermittently over years but never continuously for more than 30 days is not long-term. Second, when a device is removed and replaced by a device of the same type as part of the intended use, the durations accumulate. Continuous intended use is assessed across the sequence, not the individual insertions.

For Rule 8 specifically, the long-term threshold is the gate into the rule from the surgically invasive family. A surgically invasive device used continuously for 29 days sits in Rule 7 (short-term surgically invasive). The same device at day 31 sits in Rule 8. The class jumps from Class IIa (Rule 7 default) to Class IIb (Rule 8 default), and if any Class III escalation applies the jump is larger.

What "implantable" means in Annex VIII

The implantable definition is what pulls devices into Rule 8 that would not otherwise be caught by the long-term surgically invasive definition. Annex VIII Section 1 defines an implantable device as any device, including those that are partially or wholly absorbed, which is intended to be totally introduced into the human body, or to replace an epithelial surface or the surface of the eye, by clinical intervention, and which is intended to remain in place after the procedure. A device intended to be partially introduced into the human body by clinical intervention and to remain in place after the procedure for at least 30 days is also considered to be an implantable device.

Two consequences matter for Rule 8 scoping:

  • A device that is intended to remain in the body after the procedure is implantable regardless of how long it stays. A dissolvable suture, a bioresorbable screw, and a drug-eluting implant that fully absorbs in weeks are all implantable devices. And therefore Rule 8 applies.
  • A device that is only partially introduced. A percutaneous device, for example. Is implantable if intended to remain in place for at least 30 days. A short-term transcutaneous device is not implantable under this definition.

The partially absorbed clause is where several startup devices get caught. If any part of the device is intended to remain in the body for 30 days or more, the device is implantable, and Rule 8 applies.

The Class III escalations, one by one

The escalation list is closed. If your device does not match one of the listed categories, it stays at Class IIb. If it does, it is Class III. There is no intermediate path.

Heart or central circulatory system. "Central circulatory system" is defined in Annex VIII Section 1 and lists the specific vessels that qualify (the major arteries leading directly from the heart and the comparable large veins). A device placed in one of those vessels, or in the heart itself, or in direct contact with these parts, is Class III. Vascular stents placed in the coronary arteries, heart valves, ventricular assist devices, and pacemaker leads are classic Class III devices under this escalation.

Central nervous system. A device intended for direct contact with the central nervous system. The brain or the spinal cord. Is Class III. Intracranial electrodes, cerebrospinal fluid shunts that contact the brain, and implants in contact with the spinal cord are the typical cases.

Biological effect or wholly/mainly absorbed. A device that acts through a biological effect (not a chemical or physical effect) or that is intended to be wholly or mainly absorbed is Class III. Bioresorbable scaffolds, absorbable bone substitutes, and devices with an intended biological mode of action sit here.

Chemical change in the body (teeth excluded). A device that undergoes chemical change inside the body, such as certain bone cements and reactive fillers, is Class III unless it is placed in the teeth. The dental exclusion is narrow and specific to teeth.

Administering medicinal products. A long-term implantable device that administers a medicinal product is Class III. Drug-delivery implants and reservoir systems are covered.

Active implantable devices and their accessories. Every active implantable device is Class III, together with its accessories. Pacemakers, implantable cardioverter-defibrillators, cochlear implants, implantable neurostimulators, and implantable infusion pumps are all Class III under this escalation, and so are the accessories explicitly tied to them.

Breast implants and surgical meshes. Both categories are Class III by name in Rule 8.

Total or partial joint replacements. The joint replacement itself is Class III. Ancillary components. Screws, wedges, plates, instruments. Are excluded from the Class III escalation and classified under the other rules that apply to them.

Spinal disc replacements and devices in contact with the spinal column. Class III, with the same ancillary component exception as joint replacements.

Worked examples. Where startup devices land

A resorbable bone screw. Implantable (it is introduced by clinical intervention and intended to remain in place). It is also intended to be wholly or mainly absorbed. Rule 8 applies, and the "wholly or mainly absorbed" escalation pushes the device to Class III.

A subcutaneous sensor intended to stay in place for six months. Implantable (partially introduced and intended to remain for at least 30 days). Rule 8 applies. If the sensor does not touch the heart, central circulatory system, or central nervous system, has no biological effect, undergoes no chemical change, does not administer a medicinal product, and is not active-implantable, it stays at Class IIb.

An active implantable neurostimulator for chronic pain. Active implantable device. Class III under Rule 8 without further analysis. Its dedicated accessories are also Class III.

A dental implant. Implantable. Rule 8 applies. No Class III escalation is triggered (the chemical change exclusion specifically covers devices placed in the teeth, and the other escalations do not fit). Class IIb.

A coronary stent. Implantable. Rule 8 applies. Placed in the central circulatory system. Class III.

A hip replacement system. The total joint replacement is Class III by explicit name in Rule 8. The screws and instruments that come with the system are ancillary components and sit at the class the other applicable rules produce, not at Class III.

Common misclassifications with Rule 8

Treating "implantable" as a lifetime concept instead of an intent concept. If a device is intended to remain in the body after the procedure, it is implantable, even if the stay is short. Bioresorbable devices trip on this frequently.

Missing the 30-day rule for partially introduced devices. A percutaneous device at day 31 is implantable. At day 29 it is not. The threshold matters, and it is continuous intended use, not elapsed calendar time.

Assuming the central circulatory system means "anywhere blood flows." The definition in Annex VIII Section 1 lists specific vessels. A device in a peripheral vein is not in the central circulatory system.

Missing the dental carve-out for chemical change. Bone cements and similar reactive materials outside the teeth trigger the Class III escalation. Inside the teeth they do not.

Forgetting that active implantable accessories are also Class III. A dedicated programmer or lead that is an accessory to an active implantable device is Class III under the same escalation, even if the accessory on its own looks lower-risk.

Over-classifying ancillary components of joint and spinal systems as Class III. Screws, wedges, plates, and instruments attached to joint replacement systems or spinal devices are explicitly carved out of the Class III escalation.

Documenting "Rule 8, Class IIb" without the reasoning. A Notified Body auditor will ask why the Class III escalations do not apply. The answer must be in writing, with the intended purpose from Article 2(12) as the anchor.

The Subtract to Ship angle on Rule 8

The Subtract to Ship framework for MDR compliance treats classification as the second of four passes. Rule 8 is the part of the classification pass where subtraction gets hardest, because the temptation is either to over-classify (assume Class III to be safe) or to under-classify (hope Class IIb survives the audit). Neither is discipline. Discipline is walking through every Class III escalation in turn, documenting why each one does or does not apply to the intended purpose under Article 2(12), and landing on the class the rule actually produces.

Over-classifying a Rule 8 device from IIb to III adds mandatory clinical investigation requirements, a more expensive conformity assessment route, and substantially longer Notified Body engagement. Under-classifying from III to IIb produces a dispute during assessment and rework of the clinical and technical file. The cost of getting Rule 8 wrong in either direction is measured in quarters, not weeks.

Reality Check. Where do you stand on Rule 8?

  1. Is your device implantable under the Annex VIII Section 1 definition, including the partially introduced 30-day clause?
  2. If the device is surgically invasive but not implantable, is the continuous intended use more than 30 days (putting it in Rule 8) or less (putting it in Rule 6 or 7)?
  3. Have you walked through every Class III escalation in Rule 8 explicitly, not just the one that looks closest?
  4. For the heart and central circulatory system escalation, have you checked the definition of central circulatory system against the specific vessels your device contacts?
  5. For the absorbable / biological effect escalation, have you documented the intended mode of action in the clinical evaluation?
  6. If your device is part of a system with ancillary components, have you classified each component separately rather than pulling them all into the Class III bucket?
  7. Have you written the classification down with the specific Rule 8 sub-point and the intended purpose paragraph, so a Notified Body auditor can reconstruct the logic from your file?

Frequently Asked Questions

What is the default class under MDR Rule 8? The default class under Rule 8 is Class IIb. Rule 8 applies to all long-term surgically invasive devices and to all implantable devices. The rule then lists specific categories that escalate to Class III. If none of those categories apply, the device stays at Class IIb.

Are all implantable devices Class III under the MDR? No. Implantable devices are Rule 8 devices, and Rule 8 defaults to Class IIb. They become Class III only if they fall into one of the explicit escalations: heart or central circulatory system, central nervous system, biological effect or mainly absorbed, chemical change (teeth excluded), administering medicinal products, active implantable, breast implants and surgical meshes, joint replacements, or spinal disc replacements and devices in contact with the spinal column.

What counts as "long-term" in MDR classification? Long-term in Annex VIII means normally intended for continuous use for more than 30 days. The threshold is continuous intended use, not elapsed calendar time. When a device is replaced by a device of the same type as part of the intended use, the durations accumulate across the sequence.

Is a bioresorbable device always Class III under Rule 8? A device that is intended to be wholly or mainly absorbed triggers the Class III escalation in Rule 8. Devices that are only partially absorbable and are not intended to be mainly absorbed are assessed on whether they hit any other escalation. The intended absorption pattern stated in the technical documentation and clinical evaluation is what governs the assessment.

Are the screws and plates in a joint replacement system Class III? No. Rule 8 explicitly excludes ancillary components such as screws, wedges, plates, and instruments from the Class III escalation for total or partial joint replacements and for spinal disc replacement implants and devices in contact with the spinal column. These components are classified under the other applicable rules, which typically puts them at a lower class than the joint or spinal implant itself.

Is Rule 8 the same as the active implantable rule? Rule 8 includes active implantable devices and their accessories in the Class III escalation list, which means every active implantable device is classified as Class III under Rule 8. There is no separate active implantable rule under the MDR. The category is folded into Rule 8.

Where can I find the authoritative interpretation of Rule 8? MDCG 2021-24 (October 2021) is the MDR-era guidance on classification of medical devices. It walks through the rules including Rule 8 with examples, and together with the Annex VIII text it is the reference you cite when defending a Rule 8 classification to a Notified Body. The Borderline Manual v4 (September 2025) records case-by-case decisions that are relevant when a comparable device has already been assessed.

Sources

  1. Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, Article 2(12) (intended purpose), Article 51 (classification), Annex VIII Section 1 (definitions, including implantable device, long-term, central circulatory system, central nervous system, and active implantable device), Annex VIII Section 3 Rule 8. Official Journal L 117, 5.5.2017.
  2. MDCG 2021-24. Guidance on classification of medical devices, October 2021.

This post is part of the Device Classification and Conformity Assessment series in the Subtract to Ship: MDR blog. Authored by Felix Lenhard and Tibor Zechmeister. Rule 8 is the rule where classification errors are most expensive, because every Class III escalation adds clinical investigation, conformity assessment, and Notified Body engagement that cannot be undone once the downstream work is built against the wrong class. When a Rule 8 decision does not sit cleanly, the fastest path to a defensible answer is a classification working session with a sparring partner who has argued the same escalations across fifty-plus certifications.